Predictors of Biochemical Response to Antithyroid Drugs in Graves Disease
Researchers identified predictors of biochemical treatment response to antithyroid drugs, specifically methimazole, in patients with Graves disease.
Researchers identified predictors of biochemical treatment response to antithyroid drugs, specifically methimazole, in patients with Graves disease.
The 8th edition of the American Joint Committee on Cancer staging system does not address disparities in outcomes in differentiated thyroid cancer.
Severe depression is associated with higher thyrotropin levels, according to results of a historical cohort study conducted at the University of Utah.
Vitamin D status was not linked to risk for thyroid immune-related adverse events in patients initiating immune checkpoint inhibitor therapy.
Treatment with liraglutide for type 2 diabetes was not associated with an increased risk for hospitalization for heart failure (HF) or cardiovascular death in patients with vs without a history of HF.
Patients with rheumatoid arthritis and a higher BMI were shown to have increased foot pain and foot-related activity limitations.
The combination of higher serum oxidized low-density lipoprotein (oxLDL) and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for transient ischemic attacks.
Researchers presented the outcomes from a 2-year intervention that included bone-strengthening physical activity and dietary behaviors of children attending after-school programs in the United States.
The improvements in estimated and total body bone mineral density observed with statin treatment may be partly accounted for by their low-density lipoprotein cholesterol-lowering effect.
Rapid eye movement-related obstructive sleep apnea and other sleep disordered breathing events are associated with an increased risk for gestational diabetes.